Novo Nordisk Partners With OpenAI to Accelerate AI-Driven Drug Discovery
By
Emma Clarke
Novo Nordisk has partnered with OpenAI to enhance its drug discovery efforts using advanced AI tools, aiming to accelerate identification of new treatments.